An initial epigenetic ctDNA test targeting single DMRs in BCAT1 and IKZF1 resulted in a 62–64% sensitivity for CRC with a 92–94% specificity [10, 11]. The gene discussed is IKZF1; the disease is colorectal carcinoma.